Home / France / Teleperformance
Teleperformance
Short position disclosed on August 11, 2026.
8.94% of the capital sold short
7 disclosing funds
643 disclosures on record
Evolution of the disclosed total
0%5%10%15%
Oct 2025Jan 2026Apr 2026Jul 2026
November 30, 2017 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| POINT72 Asset Management, L.P. | 2.11% | +0.75 pt | August 4, 2026 | |
| Marshall Wace LLP | 1.79% | +0.89 pt | August 7, 2026 | |
| Citadel Advisors LLC | 1.58% | new | August 11, 2026 | |
| Jericho Capital Asset Management L.P. | 1.18% | unchanged | June 4, 2025 | |
| Squarepoint OPS LLC | 1.18% | new | July 30, 2026 | |
| Blackrock Financial Management INC. | 0.58% | new | August 11, 2026 | |
| TWO Sigma Investments, LP | 0.52% | new | June 30, 2026 |
On the other side: the funds that hold Teleperformance Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| March 8, 2024 | Qube Research & Technologies Limited | 0.88% | March 28, 2024 |
| March 8, 2024 | Marshall Wace LLP | 0.84% | September 22, 2025 |
| March 8, 2024 | Gladstone Capital Management LLP | 0.71% | May 13, 2026 |
| March 7, 2024 | Qube Research & Technologies Limited | 0.99% | March 28, 2024 |
| March 7, 2024 | Gladstone Capital Management LLP | 0.65% | May 13, 2026 |
| March 7, 2024 | Marshall Wace LLP | 0.65% | September 22, 2025 |
| March 5, 2024 | Qube Research & Technologies Limited | 1.00% | March 28, 2024 |
| February 29, 2024 | Qube Research & Technologies Limited | 0.90% | March 28, 2024 |
| February 28, 2024 | Qube Research & Technologies Limited | 0.81% | March 28, 2024 |
| February 28, 2024 | Gladstone Capital Management LLP | 0.53% | May 13, 2026 |
| February 28, 2024 | Marshall Wace LLP | 0.49% | March 1, 2024 |
| February 27, 2024 | Marshall Wace LLP | 0.66% | March 1, 2024 |
| February 21, 2024 | Marshall Wace LLP | 0.79% | March 1, 2024 |
| February 19, 2024 | Marshall Wace LLP | 0.87% | March 1, 2024 |
| February 14, 2024 | Qube Research & Technologies Limited | 0.64% | March 28, 2024 |
| February 13, 2024 | Marshall Wace LLP | 0.90% | March 1, 2024 |
| February 13, 2024 | Qube Research & Technologies Limited | 0.70% | March 28, 2024 |
| February 9, 2024 | Qube Research & Technologies Limited | 0.69% | March 28, 2024 |
| February 7, 2024 | Marshall Wace LLP | 0.80% | March 1, 2024 |
| February 1, 2024 | Qube Research & Technologies Limited | 0.49% | February 5, 2024 |
| January 31, 2024 | Marshall Wace LLP | 0.71% | March 1, 2024 |
| January 30, 2024 | Qube Research & Technologies Limited | 0.51% | February 5, 2024 |
| January 29, 2024 | Marshall Wace LLP | 0.69% | March 1, 2024 |
| January 19, 2024 | Marshall Wace LLP | 0.79% | March 1, 2024 |
| December 29, 2023 | Marshall Wace LLP | 0.83% | March 1, 2024 |
| December 22, 2023 | Marshall Wace LLP | 0.79% | March 1, 2024 |
| December 12, 2023 | Marshall Wace LLP | 0.89% | March 1, 2024 |
| December 6, 2023 | Marshall Wace LLP | 0.97% | March 1, 2024 |
| November 23, 2023 | Qube Research & Technologies Limited | 0.49% | November 27, 2023 |
| November 20, 2023 | Qube Research & Technologies Limited | 0.50% | November 27, 2023 |
| November 14, 2023 | Marshall Wace LLP | 1.00% | March 1, 2024 |
| November 8, 2023 | Gladstone Capital Management LLP | 0.48% | November 10, 2023 |
| November 2, 2023 | Gladstone Capital Management LLP | 0.59% | November 10, 2023 |
| November 1, 2023 | Gladstone Capital Management LLP | 0.61% | November 10, 2023 |
| October 30, 2023 | Marshall Wace LLP | 0.99% | March 1, 2024 |
| October 30, 2023 | Qube Research & Technologies Limited | 0.49% | November 1, 2023 |
| October 26, 2023 | Marshall Wace LLP | 1.07% | March 1, 2024 |
| October 26, 2023 | Qube Research & Technologies Limited | 0.53% | November 1, 2023 |
| October 24, 2023 | Marshall Wace LLP | 1.11% | March 1, 2024 |
| October 20, 2023 | Perbak Capital Partners LLP | 0.47% | October 24, 2023 |
| October 17, 2023 | Perbak Capital Partners LLP | 0.57% | October 24, 2023 |
| September 27, 2023 | Perbak Capital Partners LLP | 0.60% | October 24, 2023 |
| September 13, 2023 | Perbak Capital Partners LLP | 0.52% | October 24, 2023 |
| September 11, 2023 | Marshall Wace LLP | 1.01% | March 1, 2024 |
| September 1, 2023 | Perbak Capital Partners LLP | 0.49% | September 5, 2023 |
| August 22, 2023 | Marshall Wace LLP | 0.91% | March 1, 2024 |
| August 18, 2023 | Marshall Wace LLP | 0.84% | March 1, 2024 |
| August 15, 2023 | Marshall Wace LLP | 0.70% | March 1, 2024 |
| August 11, 2023 | Perbak Capital Partners LLP | 0.54% | September 5, 2023 |
| August 9, 2023 | Marshall Wace LLP | 0.61% | March 1, 2024 |
Other companies sold short in France
- Ubisoft Entertainment 13.90% of the capital sold short
- Valeo 10.92% of the capital sold short
- Renault 6.44% of the capital sold short
- FDJ United 6.17% of the capital sold short
- Remy Cointreau 5.36% of the capital sold short
- Viridien 5.25% of the capital sold short
- Alstom 5.23% of the capital sold short
- Abivax 5.04% of the capital sold short
- Worldline 4.48% of the capital sold short
- Vusiongroup 4.08% of the capital sold short
- Forvia 4.06% of the capital sold short
- Publicis Groupe SA 3.38% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Teleperformance, source AMF, data as at August 11, 2026, https://www.quivad.com/action/teleperformance?page=12